INS and cancer: Studies by re-expression of klotho in cancer cells revealed that sKl acts as a tumor suppressor by inhibiting multiple signaling pathways that include the insulin/IGF-1 pathway, FGF pathway, Wnt signaling pathway, and transforming growth factor-β1 (TGF-β1) pathway.